Delivery Order SPE2DB22D2006-SPE2DB25FW3ZH
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,376.37 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical product. This competitively awarded, firm fixed price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,328.03 firm fixed price delivery order for AIRSUPRA 90-80 MCG Inhaler 10.7GM on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside competitive contract will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,476.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhalers (10.7GM) on September 4, 2025, with an ultimate completion date of September 5, 2025. This non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of AIRSUPRA 90-80 MCG Inhaler 10.7GM with a ceiling value of $1,315.45. This delivery order is issued under a firm fixed price contract with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract has an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,832.43 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM, a pharmaceutical product for respiratory treatment. The contract was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of June 5, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,828.45 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was awarded on July 18, 2025. No set-aside designation was used in this competitive award. Performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $14,008.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhaler 10.7GM pharmaceutical supplies. This non-set-aside contract was awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively...
- The Defense Logistics Agency awarded a $3,734.64 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhalator (10.7gm) on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded contract with firm fixed pricing carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,867.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 mcg inhaler (10.7 gm) on May 30, 2025, with an ultimate completion date of June 2, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the company's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,734.64 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical supplies. Awarded on July 15, 2025, with an ultimate completion date of July 16, 2025, this firm fixed-price delivery order represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3ZHDelivery Order
The Defense Logistics Agency awarded a $7,652.36 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM, a pharmaceutical product supporting federal medical supply needs. This non-set-aside, competitively awarded contract reflects a firm fixed price delivery order with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare systems worldwide. The company is a major pharmaceutical distributor serving critical federal medical procurement requirements, with a demonstrated track record of fulfilling diverse product deliveries across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 9/3/25 |